Loading...
Novel aspects of antiplatelet therapy in cardiovascular disease
Antiplatelet therapy is a cornerstone in the secondary prophylaxis of adverse cardiovascular events such as myocardial infarction and stroke. The cyclooxygenase inhibitor aspirin remains the most frequently prescribed antiplatelet drug, followed by adenosine diphosphate P2Y(12) receptor blockers. Gl...
Na minha lista:
| Udgivet i: | Res Pract Thromb Haemost |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6046593/ https://ncbi.nlm.nih.gov/pubmed/30046748 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/rth2.12115 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|